The precise mechanism by which the cellular uptake of the endocannabinoid anandamide (AEA) occurs has been the source of much debate. In the current study, we show that neuronal differentiated CAD (dCAD) cells accumulate anandamide by a process that is inhibited in a dose-dependent manner by N-(4-hydroxyphenyl)arachidonylamide (AM404). We also show that dCAD cells express functional fatty acid amide hydrolase, the enzyme primarily responsible for anandamide metabolism. Previous data from our laboratory indicated that anandamide uptake occurs by a caveolae-related endocytic mechanism in RBL-2H3 cells. In the current study, we show that anandamide uptake by dCAD cells may also occur by an endocytic process that is associated with detergent-resistant membrane microdomains or lipid rafts. Nystatin and progesterone pretreatment of dCAD cells significantly inhibited anandamide accumulation. Furthermore, RNA interference (RNAi)-mediated knockdown of dynamin 2, a protein involved in endocytosis, blocked the internalization of the fluorescently labeled anandamide analog SKM 4-45-1 ([3Ј,6Ј-bis(acetyloxy)-
. RNAi-mediated knockdown of the ␤2 subunit of the clathrin-associated activator protein 2 complex had no effect on SKM 4-45-1 internalization. We were surprised to find that dynamin 2 knockdown in dCAD cells did not affect [ 3 H]AEA uptake. However, dynamin 2 knockdown caused a significant increase in the overall levels of intact [
3 H]AEA associated with the cells, suggesting that trafficking of [ 3 H]AEA to FAAH had been disrupted. This finding may be the result of an accumulation of the anandamide carrier protein in detergent-resistant membranes after dynamin 2 knockdown. Our studies provide evidence that the cellular uptake of anandamide may occur by a dynamin 2-dependent, caveolae-related endocytic process in dCAD cells.
The endocannabinoid anandamide (AEA) is an agonist of the cannabinoid 1 and 2 receptors (Matsuda et al., 1990; Munro et al., 1993) and some vanilloid type ion channels (Di Marzo et al., 2001; Voets and Nilius, 2003) . AEA is internalized by most cell types and is thought to be metabolized primarily by the intracellular enzyme fatty acid amide hydrolase (FAAH) (Deutsch and Chin, 1993; Di Marzo et al., 1994; Cravatt et al., 1996) . Previous studies from our laboratory have indicated that AEA uptake potentially occurs by a caveolae-related, or clathrin-independent, endocytic process (McFarland et al., 2004) . Interestingly, neurons are not thought to express caveolin-1 but do exhibit lipid raft-related endocytic processes (Cameron et al., 1997) . Thus, our studies seek to validate a neuronal-like cell line as a useful model in the study of AEA uptake and to show that AEA uptake can be disrupted by using molecular inhibitors that are specifically targeted to endocytic processes.
Cath.a cells display neuronal properties and express panneuronal markers but lack classic neuronal morphology (Suri et al., 1993; Lazaroff, 1996) . Cath.a differentiated (CAD) cells are derived from the Cath.a cell line and are characterized by the loss of the immortalizing oncogene present in Cath.a cells (Qi et al., 1997) . CAD cells also undergo a reversible morphological differentiation that is initiated when serum is removed from the cell culture media (Qi et al., 1997) . Differentiated CAD (dCAD) cells stop proliferating and extend long neuronal processes characteristic of primary neuronal cell cultures (Qi et al., 1997) . Accompanying the morphological differentiation of CAD cells is an observed change in the expression and function of several neuronal proteins. For example, dCAD cells express higher levels of tyrosine hydroxylase (Lazaroff et al., 1998) and somatostatin receptor subtype 2a (Hashemi et al., 2003) , exhibit a decrease in sodium current accompanied by an increase in potassium current (Wang and Oxford, 2000) , and display alterations in cyclic AMP-mediated signaling (Hashemi et al., 2003) . Despite reported differences in their cellular signaling and protein expression profiles, both cycling CAD (cCAD) and dCAD cells express neuron-specific proteins and display the biochemical characteristics of neuronal cells (Qi et al., 1997) .
In RBL-2H3 cells, AEA transport occurs via a clathrinindependent, or caveolae-related endocytic process, substantiated by studies using pharmacological inhibitors of endocytosis (McFarland et al., 2004) . We tested the hypothesis that the disruption of lipid rafts/detergent-resistant membranes in dCAD cells would also decrease the cellular accumulation of AEA to confirm that endocytosis may play a role in AEA uptake in neuronal cells. To avoid the potential problems associated with biochemical disruption of lipid rafts, we examined AEA uptake in dCAD cells after treatment with short interfering RNA (siRNA) to knockdown expression of the ␤2 subunit of the AP2 complex, a protein necessary for clathrin-mediated endocytosis (Huang et al., 2004) , as well as dynamin 2 (Dyn 2), a protein involved in both clathrinmediated and clathrin-independent endocytic processes (Altschuler et al., 1998; Maxfield and McGraw, 2004) . The results of our studies are consistent with a role for endocytosis in the neuronal uptake of endocannabinoids.
Materials and Methods
Cell Culture. cCAD cells were maintained in a 1:1 ratio of Ham's F-12/Dulbecco's modified Eagle's medium with 5% bovine calf serum and 5% fetal clone 1 supplemented with 1% penicillin/streptomycin, and 2 mM L-glutamine. Cells were grown in a humidified environment containing 5% CO 2 and held at the constant temperature of 37°C. cCAD cells were maintained in serum-free 1:1 Ham's F-12/ Dulbecco's modified Eagle's medium and were allowed to differentiate for 36 h before experiments to generate dCAD cells.
[ 3 H]AEA Uptake and SKM 4-45-1 Internalization Assays. CAD cells were plated at approximately 50,000 cells per well in 24-well culture dishes and then allowed to differentiate in serumfree media for 36 h. The resulting dCAD cells were then transfected with siRNA oligonucleotides as described below. After the transfection period, media were removed and 1 nM [ 3 H]AEA (labeled on the arachidonate portion of the molecule; PerkinElmer Life and Analytical Sciences, Waltham, MA) in Krebs-Ringer-HEPES (KRH) buffer (120 mM NaCl, 4.7 mM KCl, 2.2 mM CaCl 2 , 10 mM HEPES, 1.2 mM KH 2 PO 4 , and 1.2 mM MgSO 4 , pH 7.4) was added to all samples and allowed to incubate for 5 min at 37°C. To determine the effects of cholesterol depletion on AEA accumulation in dCAD cells, uptake assays were performed after a 30-min incubation in KRH buffer containing nystatin (25 g/ml) and progesterone (10 g/ml). Control cells were incubated for 30 min in 1ϫ KRH buffer. AM404 (100 M) was used to define nonspecific uptake and was added 10 min before the addition of [ 3 H]AEA at 37°C. Cells were then washed once with 1ϫ KRH buffer containing 1% bovine serum albumin, and MicroScint-20 (PerkinElmer Life and Analytical Sciences) was added to each well. The amount of tritium present was determined using a TopCount microplate scintillation and luminescence counter (PerkinElmer Life and Analytical Sciences). To verify morphological changes, cells were seeded in clear 24-well tissue culture plates for uptake assays in untransfected dCAD cells. To quantify tritium from the wells of clear plates, cells were solubilized in 1% SDS and transferred to vials containing 10 ml of EcoLite scintillation fluid (MP Biomedicals, Irvine, CA) for subsequent scintillation counting. For experiments examining SKM 4-45-1 internalization, CAD cells were treated with SKM 4-45-1 (25 M) and increasing concentrations of AM404 for 10 min in prewarmed 37°C buffer. Fluorescence was quantified using a FUSION microplate reader (PerkinElmer Life and Analytical Sciences).
Determination of Plasma Membrane Cholesterol Content. Membrane cholesterol content was determined according to a method described previously (Millard et al., 2005) . CAD cells were plated in triplicate at 5 ϫ 10 4 cells per 35-mm well in complete culture medium. Twenty-four hours later, cells were washed three times with PBS and then incubated in complete medium that had been supplemented with 10% lipoprotein-deficient fetal calf serum and 1 Ci/ml [ 3 H]cholesterol (40 Ci/mmol; GE Healthcare, Chalfont St. Giles, UK). Cells were labeled to equilibrium for 48 h. Cells were then washed three times with PBS and then treated with nystatin/ progesterone as described above. Membrane cholesterol was extracted by a 10 min incubation with medium containing 4% methyl-␤-cyclodextrin. Media was collected, cells were washed three times with PBS, and proteins were extracted. Protein concentrations were determined using the bicinchoninic acid assay. [
3 H]Cholesterol extracted into the medium was quantified by scintillation counting and normalized to total protein values.
FAAH Activity Assays. FAAH activity was determined by a modification of a previously published method (Day et al., 2001) . In brief, CAD cells were homogenized in buffer containing 20 mM Tris-HCl, 1 mM EDTA, 0.7 g/ml pepstatin A, and 0.5 g/ml leupeptin. Cell homogenates were then incubated with 5 nM [ 3 H]AEA [ethanolamine 1-3 H] (ARC, St. Louis, MO) in the presence or absence of 500 nM methyl arachidonyl fluorophosphonate (MAFP) with a reaction volume of 250 l. After the incubation, the reaction was terminated by adding 500 l of 1:1 chloroform/methanol (2ϫ assay volume) to each tube. Samples were vortexed for 30 s and centrifuged at 3900g for 1 min to separate the aqueous and organic phases. Then, 100-l aliquots were collected from both the aqueous and organic phases, and radioactivity was quantified using a TopCount Microplate scintillation and luminescence counter (PerkinElmer Life and Analytical Sciences). The [ 3 H]AEA used in these experiments was labeled on the ethanolamine portion of the molecule and not the arachidonate backbone; therefore, as FAAH activity increased so did the level of radioactivity in the aqueous phase.
Western Blot Analysis. Western blot analysis was performed as described previously (McFarland et al., 2004) . The presence of FAAH, dynamin 2, and the ␤2 subunit of the AP2 complex was detected using rabbit polyclonal anti-FAAH, rabbit polyclonal antidynamin 2 (Abcam Inc., Cambridge, MA), and mouse monoclonal anti-␤2 subunit (Novus Biologicals, Inc., Littleton, CO) primary antibodies, respectively, followed by an incubation with horseradish peroxidase-labeled goat anti-rabbit or goat anti-mouse secondary antibodies (Bio-Rad Laboratories, Hercules, CA), and enhanced chemiluminescence detection reagents. Membranes were then exposed to X-ray film.
RNAi Transfections. CAD cells were transfected with siRNA oligonucleotides (Stealth RNAi; Invitrogen, Carlsbad, CA) directed against either Dyn2 or the ␤2 subunit of the AP2 complex mRNA using the Lipofectamine 2000 (Invitrogen) RNAi transfection protocol for mammalian cells provided by Invitrogen (16 pmol of each siRNA oligo was added for every 1 l of Lipofectamine 2000 used).
For later experiments, the siLentFect Lipid Reagent was used following the manufacturer's protocol (Bio-Rad Laboratories). Protein knockdown was achieved by cotransfection of two different siRNA oligonucleotides targeted at each individual protein. The siRNA sequences were as follows: Dyn 2: NM_007871_stealth_1410, GUG-GACCUGGUUAUCCAGGAGCUAA, and NM_007871_stealth_2009, GGCAGAGAAUGAGGAUGGAGCACAA, ␤2/AP2: NM_027915_ Stealth RNAi negative control duplex was purchased from Invitrogen. Sequences of the negative (mock) control contained medium GC content and matched no known mRNA sequence in the vertebrate genome.
Confocal Microscopy. dCAD cells plated in a four-well Lab-Tek Chambered Coverglass slide (Nalge Nunc International, Rochester, NY) were transfected with the appropriate siRNA oligonucleotides. Then, 72 h after transfection, the cells were treated with the B subunit of cholera toxin conjugated to Alexa Fluor 488 (488-CT) (Invitrogen), transferrin conjugated to Alexa Fluor 488 (488-Tf) (Invitrogen), or SKM 4-45-1 (Muthian et al., 2000) for 10 min and imaged using oil immersion confocal microscopy at 60ϫ magnification with a krypton (488 nm)/argon (568 nm) laser, band pass filter at 522 to 535 nm, and a long pass filter at 588 nm.
Thin Layer Chromatography Analysis for Intact [ 3 H]AEA. dCAD cells transfected with either mock or dynamin 2-targeted siRNA were treated with [
3 H]AEA (1 nM) for 5 min and washed three times with KRH containing 1% bovine serum albumin. After the removal of the wash buffer, transfected dCAD cells were exposed to 1 ml of lysis buffer (0.5% Triton X-100, 50 mM Tris-HCl, 150 mM NaCl, and 5 mM EDTA) on ice for 20 min. The cells were then scraped and added to a 15-ml centrifuge tube kept on ice that contained 1.5 ml of 2:1 CHCl 3 /MeOH (v/v) and 8 l of 1 M HCl. The aqueous and organic phases were mixed by vortexing and then separated by centrifugation (3000g for 15 min at 4°C). The organic layer was removed from each sample, placed in a clean glass tube, and 1 ml of ice-cold CHCl 3 was added to the remaining aqueous layer. The phases were again mixed by vortexing and separated by centrifugation (3000g for 15 min at 4°C). The resulting organic layer was removed and combined with the previously extracted organic layer. The solvent from the sample was evaporated under a stream of argon. The tubes were capped and kept overnight at Ϫ20°C. The concentrated samples were resuspended in 52 l of ice-cold CHCl 3 and then divided into two spots of 20 l each onto 20-ϫ 20-cm glass-backed silica gel thin layer chromatography (TLC) plates. The mobile phase in which the TLC plates were developed consisted of 11:5 ethyl acetate/isooctane saturated with H 2 O and acetic acid. After the plates were dried, the lipids were visualized with iodine vapor. The location of the [ 3 H]AEA spot was identified by comparison with the unlabeled AEA standard. The silica corresponding to the AEA spots was then scraped off of the TLC plate into scintillation vials and allowed to equilibrate for 72 h in scintillation fluid. Radioactivity was then quantified by liquid scintillation counting.
Results
Endocannabinoid Uptake Properties of dCAD and cCAD Cells. Differentiated and undifferentiated CAD (dCAD and cCAD, respectively) cells displayed robust uptake of radiolabeled anandamide. The accumulation of AEA by CAD cells was inhibited by the AEA uptake inhibitor AM404, with a K i value in the low micromolar to high nanomolar range (Fig. 1A) . SKM 4-45-1 is a fluorescent analog of AEA (Muthian et al., 2000) . Previous results using AM404 indicate that SKM 4-45-1 is internalized by the same mechanism as AEA in C6 glioma cells (Muthian et al., 2000) . SKM 4-45-1 internalization in CAD cells was also inhibited by AM404, with K i values similar to those previously reported for inhibition of [ 3 H]AEA uptake (Fig.  1B) (Muthian et al., 2000) . Furthermore, Western blot analysis of whole cell lysates from dCAD and cCAD cells revealed that both cell types express the AEA-metabolizing enzyme FAAH ( Fig. 2A) . FAAH activity assays performed on CAD cell homogenates revealed FAAH activity that was inhibited in the presence of the FAAH inhibitor MAFP (Fig. 2B) . FAAH has been implicated in playing an important role in AEA uptake (Day et al., 2001; Glaser et al., 2003) . We were surprised to find that although FAAH was present in CAD cells, inhibition of FAAH by phenylmethylsulfonyl fluoride did not reduce AEA uptake in CAD cells (data not shown). This finding suggests that FAAH may not contribute to AEA uptake in these neuronal cells.
Effect of Nystatin/Progesterone Pretreatment on AEA Uptake. As described above, both cCAD and dCAD cells display endocannabinoid properties. However, dCAD cells are morphologically similar to primary neuronal cell cultures. Thus, dCAD cells were used for our additional studies to assess the role that endocytosis might play in the AEA uptake by a neuronal cell line. dCAD cells were treated with nystatin and progesterone to deplete membrane cholesterol levels and thereby disrupt detergent-resistant lipid raft domains. Based on the results from previous studies with RBL-2H3 cells (McFarland et al., 2004) , we expected that this treatment would decrease the specific uptake of AEA by dCAD cells. Indeed, the disruption of detergent-resistant membrane microdomains in dCAD cells resulted in an ϳ50% decrease in the specific uptake of [ 3 H]AEA (Fig. 3) . Control experiments confirmed that nystatin and progesterone treat- (Fig. 3, inset) . RNAi-Mediated Knockdown of Endocytic Machinery. The studies described above with cholesterol depletion, along with our previous work (McFarland et al., 2004) , suggested that AEA uptake occurs via a caveolae-related endocytic process. The nonspecific nature of the cholesterol depletion treatments limits interpretation of our results.
Therefore, we assessed the role of clathrin-independent versus clathrin-dependent endocytosis of AEA in dCAD cells using molecular inhibitors. Specifically, we used an RNAi approach to knockdown expression of either the ␤2 subunit of the AP2 complex or dynamin 2. Knockdown of the ␤2 subunit of the AP2 complex should only inhibit clathrin-mediated endocytosis and have no effect on clathrin-independent, or caveolae-related, endocytic processes (Johannes and Lamaze, 2002; Huang et al., 2004) . Dynamin 2, however, is a GTPase that has been shown to play a role in both clathrin-mediated and clathrin-independent endocytosis (Altschuler et al., 1998; Maxfield and McGraw, 2004) . After transfection with siRNA oligonucleotides using Lipofectamine 2000 (Invitrogen), the cells were incubated for 72 h to allow for the degradation of resident protein. Western blot analysis confirmed that we had successfully reduced the expression of both proteins by 70 to 90% (Fig. 4) . Control transfection experiments using green fluorescent protein (pEGFP-N1; Clontech, Mountain View, CA) confirmed transfection efficiency in CAD cells to be greater than 80% (data not shown), consistent with our observed knockdown effects.
To verify the effects of both ␤2 subunit and dynamin 2 knockdown, we used the Alexa Fluor 488-conjugated probes transferrin (488-Tf) and the B subunit of cholera toxin (488-CT), which are endocytosed by clathrin-dependent and lipid raft/ caveolae-related endocytic processes, respectively. As was expected, after a 10-min treatment with either probe at 37°C, RNAi knockdown of the ␤2 subunit of the AP2 complex significantly reduced the internalization of 488-Tf (Fig. 5 ) but had no effect on 488-CT endocytosis in dCAD cells compared with control (Fig. 6 ). In the case of dynamin 2, RNAi knockdown inhibited internalization of both 488-Tf (Fig. 5 ) and 488-CT (Fig. 6 ) in dCAD cells. These control experiments confirm that by knocking down expression of the ␤2 subunit of the AP2 complex we are only inhibiting clathrin-mediated endocytosis (i.e., 488-Tf internalization), whereas knockdown of dynamin 2 inhibits both clathrin-dependent endocytosis as well as a lipid raftrelated endocytic process that is clathrin-independent.
AEA Uptake after RNAi Transfection. Our results above showing AM404 inhibition of both [ 3 H]AEA and SKM 4-45-1 internalization (Fig. 1) suggest that both compounds are transported by a common process in the CAD cells. Because the fluorescence associated with SKM 4-45-1 is only observed after internalization of the compound, it is a true marker of actual uptake into the cell (Muthian et al., 2000) . To assess the effects that RNAi knockdown of endocytic machinery might have on 4 . RNAi-mediated knockdown of the ␤2 subunit of the AP2 complex and dynamin 2. dCAD cells were transfected with Stealth RNAi (Invitrogen) using Lipofectamine 2000 (Invitrogen) and then incubated at 37°C in serum-free media for 72 h to allow for protein degradation. The expression of both the ␤2 subunit of the AP2 complex and the protein dynamin 2 was decreased by Ͼ90% compared with mock siRNA (nonsense sequence) transfection. siRNA oligonucleotides had no effect on the level of control protein ␤-actin (data not shown). To control for protein loading, equal amounts of total protein (20 g) from the cell lysates were added to each well for Western blot analysis as described under Materials and Methods. Both proteins resolved at the expected molecular weights. Data are representative of three separate experiments.
AEA uptake, cells were treated with 25 M SKM 4-45-1 at 37°C for 10 min after knockdown of the expression of either the ␤2 subunit of the AP2 complex or dynamin 2. Compared with control, RNAi knockdown of the ␤2 subunit of the AP2 complex caused no observable change in the internalization of SKM 4-45-1 (Fig. 7) . However, knockdown of dynamin 2 expression abolished the SKM 4-45-1 fluorescence accumulation in dCAD cells (Fig. 7) .
In addition to examining SKM 4-45-1 accumulation, we investigated the effects of RNAi-mediated knockdown of both the ␤2 subunit of the AP2 complex and dynamin 2 on the specific uptake of [ 3 H]AEA. We were surprised to find that neither the ␤2 subunit of the AP2 complex nor dynamin 2 knockdown displayed any significant effect on the specific uptake of [ 3 H]AEA (Fig. 8) 
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at ASPET Journals on March 30, 2017 molpharm.aspetjournals.org samples of each treatment group, and the levels of intact [ 3 H]AEA were quantified by scintillation counting. TLC analysis revealed that the specific levels of intact [ 3 H]AEA were approximately 2-fold higher in dCAD cells in which dynamin 2 had been knocked down compared with mock-transfected dCAD cells (Fig. 9A) .
One explanation for the above-mentioned results could be that the knockdown of dynamin 2 altered FAAH activity. Examination of FAAH protein by Western blot analysis (Fig. 9B ) and FAAH activity (Fig. 9C) after dynamin 2 knockdown indicated that the dynamin 2 knockdown had no detectable effect on FAAH. The lack of effect on FAAH and actin levels also confirms the specificity of our dynamin 2 siRNA (Fig. 9B) .
Discussion
dCAD cells represent a biochemically and morphologically neuronal cell line that rapidly accumulates the endocannabinoid AEA and displays robust FAAH activity. Thus, dCAD cells may present a novel system useful in the study of endocannabinoid biosynthesis and inactivation.
Pharmacological inhibition of endocytosis in RBL-2H3 cells suggests that an endocytic process is involved in AEA uptake and that this process is clathrin-independent, potentially involving detergent-resistant membrane microdomains such as lipid rafts (McFarland et al., 2004) . Our present results confirm these findings in the neuronal dCAD cell line as well. Pretreatment with nystatin/progesterone to disrupt detergentresistant membrane microdomains significantly reduced the specific uptake of [ 3 H]AEA by dCAD cells by ϳ50%. An alternative explanation for our results with nystatin/progesterone could be that the treatment is generally toxic to the cells. Because a major factor determining nonspecific uptake relates to cell number, it is unlikely that the brief treatments caused a decrease in cell viability because nonspecific uptake of AEA was unaltered by the treatment (data not shown). We recognize that there is a lack of specificity associated with the chemical disruption of lipid rafts. Thus, a means of specifically disrupting endocytic processes without causing the potential nonspecific effects associated with the chemical disruption of lipid rafts was needed to assess the role that endocytosis may play in the cellular uptake of AEA.
The ␤2 subunit of the AP2 complex allows for the association of this complex with clathrin and is necessary for clathrin-mediated endocytosis to occur (Huang et al., 2004) . Transferrin is internalized by a clathrin-mediated endocytic process (Johannes and Lamaze, 2002) . As expected, RNAi knockdown of the ␤2 subunit of the AP2 complex inhibited transferrin internalization in dCAD cells but did not disrupt 3 H]AEA. Nonspecific uptake was determined using 100 M AM404. The graph represents data from three separate experiments. Statistical analysis was performed using a one-sample t test comparing with the value of 100 (mock control). ‫,ء‬ p Ͻ 0.05. The cpm values from the TLC analysis for mock cells were total ϭ 2986 Ϯ 795 and nonspecific ϭ 2243 Ϯ 407. The cpm values from the TLC analysis for dynamin 2 knockdown cells were total ϭ 3257 Ϯ 545 and nonspecific ϭ 1793 Ϯ 198. B, FAAH expression after RNAi-mediated knockdown of dynamin 2. Knockdown of dynamin 2 in cCAD cells was performed as described under Materials and Methods except siLentFect Lipid Reagent (Bio-Rad) was used as the transfection reagent for 48 h with 10 nM siRNA oligo. Western blots were performed using the polyclonal dynamin 2 antibody, monoclonal FAAH antibody (1:1000; Abnova Corporation, Taipei City, Taiwan), monoclonal actin antibody (1:2000; Sigma-Aldrich, St. Louis, MO). C, FAAH activity after RNAi-mediated knockdown of dynamin 2. FAAH activity assays were performed on whole cell lysates as described under Materials and Methods. Data shown represent means Ϯ S.D. from two experiments performed in quadruplicate.
the cellular accumulation of the cholera toxin B subunit or SKM 4-45-1, the fluorescently tagged analog of AEA. The cholera toxin B subunit is known to be internalized via a clathrin-independent (lipid raft-related) endocytic process (Johannes and Lamaze, 2002) .
Whereas its role in neurons is not completely clear, the small GTPase dynamin 2 is probably involved in both clathrin-dependent and clathrin-independent endocytic recycling (Altschuler et al., 1998; Maxfield and McGraw, 2004) . Thus, both transferrin and cholera toxin should require dynamin 2 expression for internalization to occur. RNAi knockdown of dynamin 2 significantly reduced both transferrin and cholera toxin accumulation by dCAD cells. Furthermore, dynamin 2 knockdown in dCAD cells inhibited the cellular internalization of SKM 4-45-1. Because the fluorescence associated with SKM 4-45-1 is only observed after internalization of the compound, it can be used as a marker for actual uptake (Muthian et al., 2000) . One caveat of using only [ 3 H]AEA uptake is that conventional uptake assays do not differentiate between the tritium bound to the cells or membranes and the AEA that is actually transported into the cells. Taken together, our data suggest that actual internalization of AEA by dCAD cells occurs via a clathrin-independent endocytic process. Furthermore, dynamin 2 seems to play a role in the cellular uptake of AEA by the neuronal dCAD cells. Internalization of the B subunit of cholera toxin occurs by a lipid raft-mediated endocytic process (Johannes and Lamaze, 2002) . Dynamin 2 knockdown significantly reduced 488-CT internalization in dCAD cells consistent with this dynamin 2-dependent, clathrin-independent endocytic process involving detergent-resistant membrane microdomains. An alternative approach to the knockdown of dynamin 2 or the ␤ subunit of the AP2 complex could be to use siRNA targeted to clathrin itself. We were concerned about potential membrane effects reported with clathrin knockdowns and as such, we opted to focus on proteins downstream of clathrin in the endocytic pathways (Hinrichsen et al., 2003 (Hinrichsen et al., , 2006 . Dynamin 2 knockdown displayed a profound inhibitory effect on SKM 4-45-1 internalization in dCAD cells, and yet it did not have any observable effect on the specific uptake of [ 3 H]AEA. This discrepancy may be reconciled with the observation that [ 3 H]AEA uptake assays cannot discriminate between [
3 H]AEA that has actually been internalized and [ 3 H]AEA that is binding to a target on the plasma membrane. Interestingly, a study conducted by Schmid and colleagues showed that expression of dominant-negative mutants of dynamin proteins inhibited endocytic processes but had no effect on endosomal recycling of membrane components to the cell surface (Altschuler et al., 1998) . dCAD cells that have lost functioning dynamin 2 protein during the 72-h incubation after transfection with siRNA may be accumulating the AEA carrier in the detergent-resistant membrane microdomains. Precedence for such an effect comes from studies showing that expression of dominant-negative dynamin 2 mutant causes an accumulation of transferrin receptor at the cell surface (Altschuler et al., 1998) . A similar phenomenon could be occurring with the putative AEA carrier after dynamin 2 knockdown. The accumulation of detergent-resistant membrane components at the cell surface with dynamin 2 knockdown could create a scenario in which dCAD cells, although they are not internalizing [ 3 H]AEA, are accumulating [
3 H]AEA at the membrane. This effect would be due to more [ 3 H]AEA being able to associate with the plasma membrane that is now enriched with the putative carrier protein. This experimental limitation is not an issue in the case of SKM 4-45-1 internalization assays. Fluorescence from SKM 4-45-1 is not observed until after the compound is transported into the cell, and the fluorescent component of the molecule is liberated by esterases in the cell (Muthian et al., 2000) . Thus, excess SKM 4-45-1 bound only at the membrane is not detectable.
We propose that knockdown of dynamin 2 in dCAD cells causes an accumulation of the AEA carrier in detergentresistant membrane domains at the cell surface. There is no observable difference between the [ 3 H]AEA uptake in mock siRNA-transfected and dynamin 2 siRNA-transfected dCAD cells because more [
